Setting Risk Targets for Inspection of Pharmaceutical Companies in Low and Middle Income Countries: A Four Step Approach
Pharmaceutical companies are indispensable in providing essential medicines to the global population. However, in low and middle-income countries, the regulation of these companies is often insufficient, leading to risks of substandard, falsified, or counterfeit medicines. To ensure compliance and the delivery of safe and effective medicines, inspection of pharmaceutical companies is essential. The challenge, however, […]